131 related articles for article (PubMed ID: 2082484)
1. Does low-dose aspirin prevent aortocoronary vein bypass graft occlusion? The Spanish Group for Aortocoronary Bypass Follow-up (GESIC Study).
Sanz G
Thromb Res Suppl; 1990; 12():23-6. PubMed ID: 2082484
[TBL] [Abstract][Full Text] [Related]
2. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC).
Sanz G; Pajarón A; Alegría E; Coello I; Cardona M; Fournier JA; Gómez-Recio M; Ruano J; Hidalgo R; Medina A
Circulation; 1990 Sep; 82(3):765-73. PubMed ID: 2203555
[TBL] [Abstract][Full Text] [Related]
3. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
[TBL] [Abstract][Full Text] [Related]
4. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792
[TBL] [Abstract][Full Text] [Related]
5. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
[TBL] [Abstract][Full Text] [Related]
6. Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
Chesebro JH
Thromb Res Suppl; 1990; 12():5-10. PubMed ID: 2082487
[TBL] [Abstract][Full Text] [Related]
7. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158
[TBL] [Abstract][Full Text] [Related]
8. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
Chesebro JH; Fuster V; Elveback LR; Clements IP; Smith HC; Holmes DR; Bardsley WT; Pluth JR; Wallace RB; Puga FJ
N Engl J Med; 1984 Jan; 310(4):209-14. PubMed ID: 6361561
[TBL] [Abstract][Full Text] [Related]
9. Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial.
Guiteras P; Altimiras J; Arís A; Augé JM; Bassons T; Bonal J; Caralps JM; Castellarnau C; Crexells C; Masotti M
Eur Heart J; 1989 Feb; 10(2):159-67. PubMed ID: 2647494
[TBL] [Abstract][Full Text] [Related]
10. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
[TBL] [Abstract][Full Text] [Related]
11. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency.
Hockings BE; Ireland MA; Gotch-Martin KF; Taylor RR
Med J Aust; 1993 Sep; 159(6):376-8. PubMed ID: 8377686
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and prevention of aortocoronary bypass graft occlusion.
Chesebro JH; Fuster V
Int J Clin Pharmacol Res; 1986; 6(4):261-7. PubMed ID: 3531036
[TBL] [Abstract][Full Text] [Related]
13. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.
Cataldo G; Heiman F; Lavezzari M; Marubini E
Coron Artery Dis; 1998; 9(4):217-22. PubMed ID: 9649928
[TBL] [Abstract][Full Text] [Related]
14. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
[TBL] [Abstract][Full Text] [Related]
15. Predictors of early saphenous vein aortocoronary bypass graft occlusion. The GESIC Study Group.
Paz MA; Lupon J; Bosch X; Pomar JL; Sanz G
Ann Thorac Surg; 1993 Nov; 56(5):1101-6. PubMed ID: 8239808
[TBL] [Abstract][Full Text] [Related]
16. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of anticoagulant therapy started pre-operatively in preventing coronary vein graft occlusion.
Yli-Mäyry S; Huikuri HV; Korhonen UR; Airaksinen KE; Ikäheimo MJ; Linnaluoto MK; Takkunen JT
Eur Heart J; 1992 Sep; 13(9):1259-64. PubMed ID: 1396838
[TBL] [Abstract][Full Text] [Related]
18. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
Fremes SE; Levinton C; Naylor CD; Chen E; Christakis GT; Goldman BS
Eur J Cardiothorac Surg; 1993; 7(4):169-80. PubMed ID: 8481254
[TBL] [Abstract][Full Text] [Related]
19. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
[TBL] [Abstract][Full Text] [Related]
20. Failure of combined acetylsalicylic acid and dipyridamole to prevent occlusion of aortocoronary venous bypass graft.
Thaulow E; Frøysaker T; Dale J; Vatne K
Scand J Thorac Cardiovasc Surg; 1987; 21(3):215-20. PubMed ID: 3501902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
